Table 2.

Mean relative abundances of the 25 MCRA clusters for the four treatment groups.

MCRA Cluster	Treatment				P-value
	R	A	RA	AA
0	0.5a	0.8a	1.0a	0.9a	NS
1	56.1a	21.0b	30.7b	28.6b	<0.01
2	0.2a	0.3a,b	0.9b,c	0.9c	<0.001
3	17.4a	34.7a	23.6a	25.3a	NS
4	3.1a	3.2a	3.4a	3.6a	NS
6	4.0a	4.0a	8.0a	9.0a	NS
10	1.2a	3.9b	2.7a,b	2.9a,b	<0.05
11	2.4a	0.5b	2.0a	2.8a	<0.01
13	0.1a	0.5a,b	0.8b	1.6b	<0.001
14	0.0a	0.6b	0.4b	0.5b	<0.001
32	0.0a	0.7b	1.2b	0.8b	<0.001
144	0.0a	3.4b	3.8b	4.63b	<0.001
883	0.0a	4.1b	3.8b	3.5b	<0.001
7083	11.5a	3.6b	4.6b	2.7b	<0.001
7084	1.9a	0.3b	0.7b	1a,b	<0.01
7087	0.2a	0.1b	0.2a,b	0.2a	<0.01
7089	0.3a	0.2a	0.2a	0.4a	NS
7092	0.4a	0.1b	0.1b	0.1b	<0.001
7094	0.0a	10.0b	7.8b	6.8b	<0.001
7105	0.2a	0.2a	0.1a	0.3a	NS
7159	0.1a	0.6b	0.5a,b	0.4a,b	<0.05
22291	0.3a	2.8b	1.1bc	0.9c	<0.001
23687	0.0a	4.1b	2.3b	1.8b	<0.01
23941	0.0a	0.1b	0.1b	0.4b	<0.01
23942	0.0a	0.2b	0.2b	0.1a,b	<0.01

P-values are FDR corrected and derived from Wilcoxon Pairwise comparisons of MCRA clusters between different treatment groups.